# Obakulactone Targets ACOT1 to Fight Arthritis | Health and Fitness News Page: https://stenobird.com/podcast/health-news-today-2-min-news-the-daily-news-now-7685759/obakulactone-targets-acot1-to-fight-arthritis-health-and-fitness-news Text version: https://stenobird.com/podcast/health-news-today-2-min-news-the-daily-news-now-7685759/obakulactone-targets-acot1-to-fight-arthritis-health-and-fitness-news.md Podcast: [Health News Today | 2 Min News | The Daily News Now!](https://stenobird.com/podcast/health-news-today-2-min-news-the-daily-news-now-7685759) Published: 2026-07-23T14:02:51+00:00 Episode link: https://sources.thednn.ai/782f7f247b4b28d0 Audio file: https://api.fastcast.ai/audio/a4634bc6-8bb1-4114-963d-1b694c6ac378.mp3 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/health-news-today-2-min-news-the-daily-news-now-7685759/episodes/obakulactone-targets-acot1-to-fight-arthritis-health-and-fitness-news Duration seconds: 99 ## Resource A breakthrough discovery could soon offer new hope for rheumatoid arthritis sufferers: scientists have identified obakulactone (OL), a compound from traditional Chinese medicine, as a powerful anti-inflammatory agent. OL works by targeting the protein ACOT1 and rebalancing harmful fats in the body, effectively calming the inflammation that ravages joints. In rat studies, OL dramatically reduced swelling, repaired cartilage, and even restored immune organ health. It also slashed key inflammatory markers like IL-6 and TNF-alpha. This deep molecular insight not only reveals OL’s mechanism but also highlights ACOT1 as a promising new drug target — potentially paving the way for smarter, more effective RA treatments. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/782f7f247b4b28d0 ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/health-news-today-2-min-news-the-daily-news-now-7685759/episodes/obakulactone-targets-acot1-to-fight-arthritis-health-and-fitness-news/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/health-news-today-2-min-news-the-daily-news-now-7685759/obakulactone-targets-acot1-to-fight-arthritis-health-and-fitness-news.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.